Amicus Therapeutics, Inc. (NASDAQ:FOLD) made headlines on Friday as it soared to a new 52-week high, closing at $14.18 per share. This significant jump of 30.21 percent was fueled by…

Subscribe Now for Real-time Updates on the Latest Stories!
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favorite stories in this weekly newsletter.…
During Joe Biden's presidency, Republicans voiced their concerns about the abuse of power, particularly when it came to issues like…
Together AI, a startup that offers access to artificial intelligence computing, has successfully raised $305 million in a recent funding…
As a former economics professor at the Naval Postgraduate School, I always emphasized the importance of comparative advantage to my…
The deadline for millions of businesses to report their "beneficial ownership information" has been extended to March 21 by the…
Unlock the White House Watch newsletter for free Your guide to what the 2024 US election means for Washington and…
Stock market short sellers have had a rough start to 2025, with losses totaling $73 billion in the US and…
Economists often rely on the concept of "revealed preference" to understand people's beliefs through their actual behavior. This approach has…
Sign in to your account